Vitamin DVitamin D
vitamin
别名: Cholecalciferol (D3), Ergocalciferol (D2), Calciferol, Calcidiol
About
Vitamin D binds to receptors on cardiomyocytes, vascular smooth muscle, and endothelial cells, regulating calcium handling and the renin-angiotensin-aldosterone system. Observational studies show deficiency (<20 ng/mL) is associated with 50-80% increased cardiovascular risk, though the VITAL trial (25,871 participants) found supplementation did not significantly reduce major cardiovascular events.
How It Works
Binds to vitamin D receptors (VDR) on cardiomyocytes, vascular smooth muscle, and endothelial cells regulating calcium handling and contractile function; modulates the renin-angiotensin-aldosterone system (RAAS) — deficiency upregulates renin contributing to hypertension; suppresses vascular inflammation via NF-kB inhibition; supports endothelial nitric oxide synthase (eNOS) expression.
Evidence For Conditions
| 健康状况 | 等级 | 研究数量 | 受试者 | |
|---|---|---|---|---|
| High Blood Pressure (Hypertension) | C | 20 | 30000 | 查看 → |
| Heart Failure | C | 6 | 3000 | 查看 → |
Side Effects
- Hypercalcemia at very high doses (fatigue, nausea, kidney stones)
- Constipation
- Generally very safe at recommended doses
Drug & Supplement Interactions
- Thiazide diuretics (may increase hypercalcemia risk)
- Statins (theoretical interaction via CYP enzymes)
- Corticosteroids (may reduce vitamin D absorption)
- Weight loss medications (may reduce absorption of fat-soluble vitamins)
请务必告知您的医疗保健提供者您正在服用的所有补充剂。
Related Ingredients
FDA 免责声明: 这些声明未经美国食品药品监督管理局(FDA)评估。本网站上的产品和信息无意用于诊断、治疗、治愈或预防任何疾病。所展示的证据等级基于我们对已发表的同行评审研究的分析,不构成医疗建议。在开始任何补充剂方案之前,请务必咨询您的医疗保健提供者。